Telix agrees to buy ITM Isotope Technologies Munich for USD 1.65 billion upfront, plus up to USD 700 million milestones
Telix Pharmaceuticals agreed to acquire ITM Isotope Technologies Munich for USD 1.65 billion on a cash-free, debt-free basis. Consideration includes USD 1.25 billion in 105,800,000 Telix shares priced at USD 11.84, USD 302 million net debt assumed. Deal also includes up to USD 700 million in contingent payments tied to